Innodata Inc. (NASDAQ: INOD) — FY 2022 Form 10-K
Reporting period: Fiscal year ended December 31, 2022. This is an annual report, not a standalone fourth-quarter report. Comparisons are with FY 2021. Innodata provides data engineering, AI data preparation and integration services, and AI-enabled platforms through its DDS, Synodex, and Agility segments.
Financial performance and liquidity
| Metric | FY 2022 | FY 2021 |
|---|---|---|
| Revenue | $79.0 million | $69.8 million |
| Direct operating costs | $51.5 million | $43.5 million |
| Gross profit, calculated as revenue less direct operating costs | $27.5 million; 34.8% margin | $26.3 million; 37.7% margin |
| Selling and administrative expenses | $37.9 million | $27.9 million |
| Operating loss | $10.5 million; 13.3% operating loss margin | $1.5 million; 2.2% operating loss margin |
| Net loss attributable to Innodata | $11.9 million; $0.44 per share | $1.7 million; $0.06 per share |
| Adjusted EBITDA, non-GAAP | Loss of $3.3 million | Income of $3.0 million |
| Operating cash flow | Use of $1.2 million | Generation of $5.2 million |
| Cash and cash equivalents | $9.8 million | $18.9 million |
| Working capital | $2.9 million | $12.7 million |
FY 2022 investing cash outflow was $7.0 million, including $6.5 million of capital expenditures and $0.5 million of short-term investments. Financing cash outflow was $0.3 million. At year-end, long-term obligations were $6.0 million, largely pension obligations; operating lease liabilities totaled $4.7 million. The company reported no bank facilities or line of credit.
Segment revenue was DDS $56.5 million, Synodex $7.1 million, and Agility $15.4 million. Non-U.S. customers accounted for 38% of revenue, down from 45% in FY 2021. One DDS customer represented approximately 11% of FY 2022 revenue. The five largest customers together accounted for 50% of receivables, or $4.7 million.
Material changes versus FY 2021
- Revenue rose 13%, with growth in DDS (8%), Synodex (71%), and Agility (18%). Management attributed the increases to higher customer volumes and, for Agility, subscriptions and newswire products.
- Operating costs grew faster than revenue: direct operating costs increased 18% and selling and administrative expenses increased 36%. Higher headcount, salaries, software development, marketing, and other growth investments contributed to the increases.
- Net loss widened to $11.9 million from $1.7 million, and Adjusted EBITDA declined to a $3.3 million loss from $3.0 million of income. FY 2021 included a $0.6 million PPP loan-forgiveness gain.
- Cash declined by $9.1 million during FY 2022, and working capital fell by $9.8 million. Capital expenditures increased to $6.5 million from $4.4 million.
- By segment, DDS reported $4.1 million of Adjusted EBITDA versus $7.2 million in FY 2021; Synodex reported a $1.7 million loss versus $1.4 million; and Agility reported a $5.7 million loss versus $2.8 million.
Outlook, risks, contingencies, and other notable items
- Management estimated FY 2023 capital expenditures of approximately $6.0 million for technology, equipment, platform development, and infrastructure upgrades; some may be financed. It said cash and operating cash flows were expected to meet needs for at least 12 months from the financial statements’ issuance, while cautioning that the company has no credit facilities.
- Growth priorities include new customer acquisition, expansion within existing accounts, and investment in AI capabilities and platforms. The filing gives no specific revenue or earnings guidance. Management reported adding an average of 126 new customers per year in 2022, compared with averages of 93 in 2021 and 62 in 2020, as stated in the filing.
- Customer concentration and project-based work are significant risks: many contracts can be terminated on 30 to 90 days’ notice, and customer volumes may be reduced, delayed, or canceled. Agility also depends on third-party content providers.
- A Philippine former-employee judgment has a stated potential amount of approximately $5.9 million plus accrued interest. A U.S. preliminary injunction preventing enforcement against Innodata remained in effect; the company says substantial recovery could materially affect it. Other legal claims were assessed as having approximately $450,000 of reasonably possible losses beyond recorded amounts.
- An Indian tax dispute concerns the classification of services provided from July 2012 through November 2016. If the tax authority prevails, the related revenue base was approximately $57.0 million and service tax could be 12.36% to 15%, plus possible interest and penalties. No liability was recorded. Separately, approximately $0.8 million of service-tax credits remained recorded as a receivable amid a contested refund matter.
- The company reported $1.7 million of unrecognized tax benefits and approximately $50.9 million of indefinitely reinvested foreign earnings. Repatriation could result in withholding taxes. Currency movements, wage inflation, pricing pressure, competition, cybersecurity and privacy obligations, and international operating conditions are also cited risks.
- No goodwill or intangible-asset impairment was identified in the FY 2022 tests. The company recorded $3.3 million of stock-based compensation. Its financial statements received an unqualified audit opinion; management concluded disclosure controls and internal control over financial reporting were effective at year-end. The auditor did not attest to internal control effectiveness.
Important facts for investors to verify
- Whether revenue growth can translate into improved margins and positive operating cash flow, given the sharp increase in selling and administrative costs.
- Cash runway and funding needs, including the planned $6.0 million of FY 2023 capital expenditures and the absence of a bank line of credit.
- Customer concentration, contract termination terms, receivable collectability, and replacement of completed or reduced projects.
- Developments and potential exposure in the Philippine litigation and Indian tax matters, including whether recorded reserves or receivables change.
- Progress and economics of Synodex and Agility, which continued to report segment losses, and the assumptions supporting the no-impairment conclusion.
- Potential dilution and compensation expense from outstanding stock awards; verify updated share counts and equity-plan disclosures.